8p23.1 duplication syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:251076Q92.3
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

8p23.1 duplication syndrome (also known as trisomy 8p23.1) is a rare chromosomal disorder caused by a duplication of genetic material on the short arm of chromosome 8 at the 8p23.1 region. This region contains several important genes, including GATA4, which plays a role in heart development. The duplication can occur de novo (as a new event) or may be inherited from a parent who carries a balanced chromosomal rearrangement, such as an inversion of the 8p23.1 region, which is relatively common in the general population. The syndrome primarily affects neurodevelopment and can involve the cardiovascular system. Key clinical features include developmental delay, mild to moderate intellectual disability, speech and language delays, and behavioral difficulties. Congenital heart defects, particularly atrioventricular septal defects and other cardiac anomalies, have been reported in some individuals due to the involvement of the GATA4 gene. Dysmorphic facial features may be present but are often subtle and can include a broad forehead, widely spaced eyes, and a short nose. Some individuals may also exhibit mild growth abnormalities. The clinical presentation of 8p23.1 duplication syndrome is variable, and some carriers may be only mildly affected or even asymptomatic, making diagnosis challenging. There is no specific cure for this condition. Management is supportive and symptom-based, including early intervention programs, speech therapy, educational support, and cardiac evaluation and treatment when congenital heart defects are present. Genetic counseling is recommended for affected families, particularly given the possibility of parental carrier status for balanced rearrangements involving the 8p23.1 region.

Also known as:

Clinical phenotype terms— hover any for plain English:

Adrenal insufficiencyHP:0000846ExostosesHP:0100777
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for 8p23.1 duplication syndrome.

View clinical trials →

No actively recruiting trials found for 8p23.1 duplication syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the 8p23.1 duplication syndrome community →

No specialists are currently listed for 8p23.1 duplication syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to 8p23.1 duplication syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open 8p23.1 duplication syndromeForum →

No community posts yet. Be the first to share your experience with 8p23.1 duplication syndrome.

Start the conversation →

Latest news about 8p23.1 duplication syndrome

No recent news articles for 8p23.1 duplication syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about 8p23.1 duplication syndrome

What is 8p23.1 duplication syndrome?

8p23.1 duplication syndrome (also known as trisomy 8p23.1) is a rare chromosomal disorder caused by a duplication of genetic material on the short arm of chromosome 8 at the 8p23.1 region. This region contains several important genes, including GATA4, which plays a role in heart development. The duplication can occur de novo (as a new event) or may be inherited from a parent who carries a balanced chromosomal rearrangement, such as an inversion of the 8p23.1 region, which is relatively common in the general population. The syndrome primarily affects neurodevelopment and can involve the cardio

At what age does 8p23.1 duplication syndrome typically begin?

Typical onset of 8p23.1 duplication syndrome is neonatal. Age of onset can vary across affected individuals.